https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2021/06/img-floater-3.png
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2021/06/img-floater-2.png

Americas Biologics CMO Tracker

bt_bb_section_bottom_section_coverage_image

Overview

Explore 150+ North America-based contract manufacturing organizations engaged in the contract services of manufacturing biologics products including antibodies, vaccines, recombinant products, cell & gene therapy products among others, starting from cell-line development to fill & finish.
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2022/07/Overview.png
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2021/06/img-dotted-separator-2.png

Key Parameters

  • in-house capabilities
  • product types and sub-products
  • bioprocessing capabilities & processes
  • the scale of operation or phases of development
  • plant capacity & batch size
  • facility size
  • current & completed projects of CMOs
  • facility name
  • location
  • establishment year
  • facility size & capacity
  • process technology
  • bioreactor type
  • technology/service providers
  • ongoing projects/pipeline
  • annual production
  • batch size
  • bioprocessing equipment
  • bioreactors
  • expression system
  • upstream technology/ services
  • downstream technology/services
  • facility operation technology/services
  • drug product technology/services
  • regulatory approval
  • investments
  • future expansion plans
  • partnerships & collaborations and other parameters
bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image

Regions Coverage

From evolving customer expectations and emerging technologies to more nimble companies entering industries, businesses today are more at risk for disruption than ever before.
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2022/07/2983550-1280x853.jpg
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2022/07/Overview.png

Competitive Assessment

This tracker provides an in-depth overview of the North American Biologics CMOs and their manufacturing capabilities. Through this tracker, IMAPAC aims to assist organizations to keep track of CMOs in the region and identify any opportunities for strategic partnerships or investments to speed biologics products to market.

Top Highlights

The tracker offers majority of the CMOs coverage in North America, particularly in the US. Some of the key Biologics CMOs covered in this tracker are KBI Biopharma Inc, FloridaBiologix, Cognate BioServices, MassBiologics, Goodwin Biotechnology, VGXI, In, Cytovance Biologics, Inc., and many other key CMOs operating in North America.
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2022/07/Overview.png

Pick the right plan!

From evolving customer expectations and emerging technologies to more nimble companies entering industries, businesses today are more at risk for disruption than ever before.
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2021/06/img-floater-2.png
Silver
$4000
  • access upto 3 months
  • single user
  • quarterly updates
Gold
$6000
  • access upto 6 months
  • single user
  • quarterly updates
  • 3 hours dedicated analyst time one time usage
https://biopharmamarketintelligence.imapac.com/wp-content/uploads/2021/06/img-floater-3.png
Premium
$12,000
  • access for 1 year
  • Single Users
  • Monthly update's
  • 3 hours dedicated analyst time each month